Study of the Effect of Imagery Rehearsal Therapy (IRT) of Nightmares
A Randomised Controlled Trial of Imagery Rehearsal Therapy (IRT) of Nightmares in a Psychiatric Population
1 other identifier
interventional
112
1 country
3
Brief Summary
The purpose of this study is to determine whether Imagery Rehearsal Therapy(IRT) is effective in the reduction of the number of nightmares and the nightmare distress in a population of patients with psychiatric disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Feb 2006
Longer than P75 for phase_1
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 10, 2006
CompletedFirst Posted
Study publicly available on registry
February 13, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedOctober 17, 2013
October 1, 2013
4.9 years
February 10, 2006
October 16, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Frequency of nightmares scored in prospective daily nightmare logs
Daily logs for 18 weeks, then periods of 4 weeks every 3 months
Frequency of nightmares scored on the Nightmare Frequency Questionnaire
At beginning of trial, 4, 16, 30, 42 and 56 weeks
Secondary Outcomes (8)
Intensity of nightmares scored in prospective daily nightmare logs
Daily logs for 18 weeks, then periods of 4 weeks every 3 months
Effects of nightmares scored on the Nightmare Effects Survey
1, 4, 16, 30, 42 and 56 weeks
Nightmare distress scored on the Nightmare Distress Questionnaire
1, 4, 16, 30, 42 and 56 weeks
Sleep problems scored on the SLEEP-50
1, 4, 16, 30, 42 and 56 weeks
Psychiatric symptoms scored on the Symptom Check List (SCL-90)
1, 4, 16, 30, 42 and 56 weeks
- +3 more secondary outcomes
Study Arms (2)
IRT
EXPERIMENTALPatients randomly assigned to the IRT condition receive Imagery Rehearsal Therapy after 4 weeks since the entrance into the trial next to their treatment as usual.
TAU
NO INTERVENTIONPatients that are randomly assigned to the waiting list control condition get treatment as usual (TAU) and complete the daily nightmare logs for a period of three months. These patients get the IRT intervention after waiting for 6 months.
Interventions
Imagery Rehearsal Therapy is given by psychologists, psychotherapists or psychiatrists. The IRT therapists are all trained by Annette van Schagen, principal investigator. IRT consists of six 1-hour sessions. The six sessions are given in a period of three months. Each session is described in the IRT Manual. The IRT Manual is devised by the principal investigator Annette van Schagen in colaboration with Victor Spoormaker PhD. There is a patient version of the IRT manual available for the patients, which includes descriptions of the IRT sessions and homework assignments.
Eligibility Criteria
You may qualify if:
- Minimum of 3 nightmares per month
- Nightmares are associated with distress in daily life
- Subject wants to get treatment for the nightmares
You may not qualify if:
- Imagery rehearsal therapy for nightmares in the past
- Psychotic disorders
- Acute psychiatric crisis
- Mentally challenged or neuropsychiatric syndrome
- Severe addiction problems
- Insufficient mastery of the Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GGZ Centraallead
- Utrecht Universitycollaborator
Study Sites (3)
GGZ Centraal, De Meregaard
Almere Stad, 1326 AD, Netherlands
GGZ Centraal, Zon & Schild
Amersfoort, 3818 EW, Netherlands
GGZ Centraal, De Rembrandthof
Hilversum, 1200 AE, Netherlands
Related Publications (9)
Krakow B, Hollifield M, Johnston L, Koss M, Schrader R, Warner TD, Tandberg D, Lauriello J, McBride L, Cutchen L, Cheng D, Emmons S, Germain A, Melendrez D, Sandoval D, Prince H. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA. 2001 Aug 1;286(5):537-45. doi: 10.1001/jama.286.5.537.
PMID: 11476655BACKGROUNDSpoormaker VI, Schredl M, van den Bout J. Nightmares: from anxiety symptom to sleep disorder. Sleep Med Rev. 2006 Feb;10(1):19-31. doi: 10.1016/j.smrv.2005.06.001. Epub 2005 Dec 27.
PMID: 16377217BACKGROUNDBenca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry. 1992 Aug;49(8):651-68; discussion 669-70. doi: 10.1001/archpsyc.1992.01820080059010.
PMID: 1386215BACKGROUNDBlagrove M, Farmer L, Williams E. The relationship of nightmare frequency and nightmare distress to well-being. J Sleep Res. 2004 Jun;13(2):129-36. doi: 10.1111/j.1365-2869.2004.00394.x.
PMID: 15175092BACKGROUNDRothbaum BO, Mellman TA. Dreams and exposure therapy in PTSD. J Trauma Stress. 2001 Jul;14(3):481-90. doi: 10.1023/A:1011104521887.
PMID: 11534880BACKGROUNDSpoormaker VI, Verbeek I, van den Bout J, Klip EC. Initial validation of the SLEEP-50 questionnaire. Behav Sleep Med. 2005;3(4):227-46. doi: 10.1207/s15402010bsm0304_4.
PMID: 16190812BACKGROUNDStrine TW, Chapman DP. Associations of frequent sleep insufficiency with health-related quality of life and health behaviors. Sleep Med. 2005 Jan;6(1):23-7. doi: 10.1016/j.sleep.2004.06.003.
PMID: 15680291BACKGROUNDvan de Willige G, Wiersma D, Nienhuis FJ, Jenner JA. Changes in quality of life in chronic psychiatric patients: a comparison between EuroQol (EQ-5D) and WHOQoL. Qual Life Res. 2005 Mar;14(2):441-51. doi: 10.1007/s11136-004-0689-y.
PMID: 15892433BACKGROUNDvan Schagen AM, Lancee J, de Groot IW, Spoormaker VI, van den Bout J. Imagery rehearsal therapy in addition to treatment as usual for patients with diverse psychiatric diagnoses suffering from nightmares: a randomized controlled trial. J Clin Psychiatry. 2015 Sep;76(9):e1105-13. doi: 10.4088/JCP.14m09216.
PMID: 26455674DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annette M. van Schagen, MA
GGZ Centraal (previously Symfora groep)
- STUDY CHAIR
Jan van den Bout, PhD
Utrecht University
- STUDY CHAIR
Victor I. Spoormaker, PhD
Max-Planck-Institute of Psychiatry
- STUDY CHAIR
Jaap Lancee, PhD
University of Amsterdam
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical psychologist
Study Record Dates
First Submitted
February 10, 2006
First Posted
February 13, 2006
Study Start
February 1, 2006
Primary Completion
January 1, 2011
Study Completion
August 1, 2011
Last Updated
October 17, 2013
Record last verified: 2013-10